PhD in cardiovascular genetics from Karolinska Institute, Sweden. Research according to an overarching theme of my research is the use of high-throughput omics to bridge the gap between research and medicine. My initial interest was in expression quantitative trait loci (eQTL), and their possibilities for translating genetics to medical use. This followed a further step into actual industrial drug and pharmacogenetics development from the technique, performed at Novo Nordisk, Denmark. Current interests focus on further translation of main genetics results into actual use both in the clinical context of response stratification and in the industrial context of drug development.